Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Late Residual γ-H2AX Foci in Murine Spinal Cord Might Facilitate Development of Response-modifying Strategies: A Research Hypothesis

NICOLAUS ANDRATSCHKE, TOBIAS BLAU, SABINE SCHILL and CARSTEN NIEDER
Anticancer Research February 2011, 31 (2) 561-564;
NICOLAUS ANDRATSCHKE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOBIAS BLAU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SABINE SCHILL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CARSTEN NIEDER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: carsten.nieder{at}nlsh.no
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 31 no. 2 561-564
PMID 
21378339

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received December 1, 2010
  • Revision received January 11, 2011
  • Accepted January 12, 2011
  • Published online March 4, 2011.

Copyright & Usage 
Copyright© 2011 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. NICOLAUS ANDRATSCHKE1,
  2. TOBIAS BLAU1,2,
  3. SABINE SCHILL1 and
  4. CARSTEN NIEDER3,4
  1. 1Department of Radiation Oncology, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
  2. 2Department of Neuropathology, University Hospital of Cologne, Cologne, Germany
  3. 3Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway
  4. 4Institute of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway
  1. Correspondence to: Carsten Nieder, MD, Department of Oncology and Palliative Medicine, Nordland Hospital, 8092 Bodø, Norway. Tel: +47 75578449, Fax: +47 75534209, e-mail: carsten.nieder{at}nlsh.no
View Full Text

Statistics from Altmetric.com

Cited By...

  • 3 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 31, Issue 2
February 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Late Residual γ-H2AX Foci in Murine Spinal Cord Might Facilitate Development of Response-modifying Strategies: A Research Hypothesis
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Late Residual γ-H2AX Foci in Murine Spinal Cord Might Facilitate Development of Response-modifying Strategies: A Research Hypothesis
NICOLAUS ANDRATSCHKE, TOBIAS BLAU, SABINE SCHILL, CARSTEN NIEDER
Anticancer Research Feb 2011, 31 (2) 561-564;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Late Residual γ-H2AX Foci in Murine Spinal Cord Might Facilitate Development of Response-modifying Strategies: A Research Hypothesis
NICOLAUS ANDRATSCHKE, TOBIAS BLAU, SABINE SCHILL, CARSTEN NIEDER
Anticancer Research Feb 2011, 31 (2) 561-564;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan–Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer
  • MMP-9 Genotypes Serve as Oral Cancer Predictive Marker for Smokers
  • A RANKL-derived Peptide Inhibits RSPO3-LGR4-Wnt Signaling and Lung Adenocarcinoma in Mice
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire